Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
OPCH

OPCH - Option Care Health Inc Stock Price, Fair Value and News

29.29USD-0.64 (-2.14%)Market Closed

Market Summary

OPCH
USD29.29-0.64
Market Closed
-2.14%

OPCH Stock Price

View Fullscreen

OPCH RSI Chart

OPCH Valuation

Market Cap

5.4B

Price/Earnings (Trailing)

19.81

Price/Sales (Trailing)

1.22

EV/EBITDA

13.26

Price/Free Cashflow

31.62

OPCH Price/Sales (Trailing)

OPCH Profitability

Operating Margin

89.07%

EBT Margin

8.15%

Return on Equity

19.08%

Return on Assets

8.39%

Free Cashflow Yield

3.16%

OPCH Fundamentals

OPCH Revenue

Revenue (TTM)

4.4B

Rev. Growth (Yr)

12.82%

Rev. Growth (Qtr)

1.93%

OPCH Earnings

Earnings (TTM)

272.7M

Earnings Growth (Yr)

14.24%

Earnings Growth (Qtr)

-21.66%

Breaking Down OPCH Revenue

Last 7 days

-5.2%

Last 30 days

-10.8%

Last 90 days

-5.8%

Trailing 12 Months

-7.3%

How does OPCH drawdown profile look like?

OPCH Financial Health

Current Ratio

1.77

Debt/Equity

0.74

Debt/Cashflow

0.2

OPCH Investor Care

Buy Backs (1Y)

3.30%

Diluted EPS (TTM)

1.53

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20244.4B000
20234.0B4.1B4.2B4.3B
20223.6B3.7B3.8B3.9B
20211.8B1.9B2.7B3.4B
20202.5B2.8B2.3B1.7B
20192.0B2.0B2.1B2.3B
20181.1B1.3B1.6B1.9B
2017914.9M900.6M874.7M817.2M
2016976.3M961.9M939.2M935.6M
2015945.7M962.5M978.2M982.2M
2014809.8M867.6M908.4M922.7M
2013688.0M704.4M724.7M769.5M
2012579.3M603.6M640.2M662.6M
2011461.7M492.6M523.6M554.5M
20101.3B1.4B1.5B430.7M
20091.4B1.4B1.4B1.3B
20081.2B1.3B1.4B1.4B
20070001.2B
19970000
Get all data in R, Python etc through our Historical Stock Data APIs
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Option Care Health Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
bodem barbara w.
acquired
-
-
1,731
-
Apr 01, 2024
wright norman l.
acquired
-
-
1,731
-
Mar 09, 2024
whitworth luke
sold (taxes)
-44,402
32.34
-1,373
chief operating officer
Feb 28, 2024
bavaro michael
sold
-62,944
31.7259
-1,984
chief human resources officer
Feb 26, 2024
kraemer harry m jansen jr
bought
1,104,350
31.5529
35,000
-
Feb 23, 2024
shapiro michael h.
sold (taxes)
-809,514
32.24
-25,109
chief financial officer
Feb 23, 2024
whitworth luke
sold (taxes)
-251,408
32.24
-7,798
chief operating officer
Feb 23, 2024
whitworth luke
sold (taxes)
-18,215
32.24
-565
chief operating officer
Feb 23, 2024
grashoff christopher l.
sold (taxes)
-6,996
32.24
-217
chief growth officer
Feb 23, 2024
rademacher john charles
sold (taxes)
-3,199,880
32.24
-99,252
chief executive officer

1–10 of 50

Which funds bought or sold OPCH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 24, 2024
Newbridge Financial Services Group, Inc.
new
-
738
738
 -%
Apr 24, 2024
Spire Wealth Management
unchanged
-
90.00
2,012
 -%
Apr 24, 2024
HMS Capital Management, LLC
sold off
-100
-208,811
-
 -%
Apr 24, 2024
Assenagon Asset Management S.A.
added
0.86
112,933
27,803,700
 0.07%
Apr 24, 2024
Cambridge Investment Research Advisors, Inc.
added
1.22
3,000
378,000
 -%
Apr 24, 2024
First Pacific Financial
added
44.12
498
1,644
 -%
Apr 24, 2024
DekaBank Deutsche Girozentrale
unchanged
-
-6,000
290,000
 -%
Apr 23, 2024
FIFTH THIRD BANCORP
added
10.67
8,837
95,656
 -%
Apr 23, 2024
AMALGAMATED BANK
reduced
-15.7
-594,000
3,101,000
 0.03%
Apr 23, 2024
REGIONS FINANCIAL CORP
added
0.86
1,606
394,095
 -%

1–10 of 48

Are Funds Buying or Selling OPCH?

Are funds buying OPCH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own OPCH
No. of Funds

Unveiling Option Care Health Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
11.08%
19,626,205
SC 13G/A
Jan 23, 2024
blackrock inc.
11.9%
21,132,010
SC 13G/A
Sep 11, 2023
vanguard group inc
10.09%
18,142,964
SC 13G/A
Jun 12, 2023
fmr llc
-
0
SC 13G/A
Jun 12, 2023
walgreens boots alliance, inc.
0.0%
0
SC 13D/A
Mar 03, 2023
walgreens boots alliance, inc.
6.0%
10,771,926
SC 13D/A
Feb 14, 2023
price t rowe associates inc /md/
1.4%
2,469,612
SC 13G/A
Feb 09, 2023
fmr llc
-
0
SC 13G/A
Feb 09, 2023
vanguard group inc
8.53%
15,524,268
SC 13G/A
Jan 23, 2023
blackrock inc.
10.9%
19,772,386
SC 13G/A

Recent SEC filings of Option Care Health Inc

View All Filings
Date Filed Form Type Document
Apr 23, 2024
10-Q
Quarterly Report
Apr 23, 2024
3
Insider Trading
Apr 23, 2024
8-K
Current Report
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
ARS
ARS
Apr 03, 2024
DEF 14A
DEF 14A
Apr 03, 2024
DEFA14A
DEFA14A
Mar 14, 2024
8-K
Current Report
Mar 12, 2024
4
Insider Trading

Peers (Alternatives to Option Care Health Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
UNH
455.4B
371.6B
 0.35% 2.29%
20.35
1.23
 14.64% 11.24%
CI
103.7B
195.3B
 -0.89% 42.87%
19.3
0.53
 8.17% -20.79%
CVS
84.7B
357.8B
 -15.14% -6.85%
10.14
0.24
 10.95% 93.52%
HCA
83.0B
65.0B
 -4.22% 12.88%
15.84
1.28
 7.86% -7.11%
CNC
40.5B
154.0B
 -2.44% 13.57%
14.98
0.26
 6.54% 124.79%
DVA
11.6B
12.1B
 -1.82% 53.92%
16.84
0.96
 4.57% 23.40%
UHS
11.4B
14.3B
 -6.87% 15.65%
15.95
0.8
 6.59% 6.24%
MID-CAP
CHE
8.7B
2.3B
 -10.00% 2.41%
31.85
3.83
 6.06% 9.17%
ACHC
6.8B
2.9B
 -4.41% -0.94%
-312.68
2.31
 12.20% -107.93%
AMN
2.1B
3.8B
 -9.00% -34.66%
10.11
0.56
 -27.73% -52.50%
AMEH
2.0B
1.4B
 -7.34% 3.16%
33.37
1.46
 21.19% 34.42%
SMALL-CAP
ADUS
1.5B
1.1B
 -10.65% -18.57%
23.8
1.41
 11.31% 35.83%
BKD
1.3B
3.0B
 6.69% 62.95%
-6.87
0.43
 6.74% 20.73%
BEAT
51.9M
-
 -9.63% 1.03%
-3.54
-
 - -12.94%
AMS
19.7M
21.3M
 20.46% 12.23%
37.05
0.93
 8.00% -62.25%

Option Care Health Inc News

Latest updates
Yahoo Finance • 63 minutes ago
Results: Option Care Health, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
MarketBeat • 18 hours ago
Option Care Health, Inc. (NASDAQ:OPCH) Forecasted to Post Q1 2025 Earnings of $0.30 Per Share
Simply Wall St • 42 hours ago
Option Care Health, Inc. (NASDAQ:OPCH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Seeking Alpha • 23 Apr 2024 • 07:20 pm
Option Care Health, Inc. (OPCH) Q1 2024 Earnings Call Transcript
InvestorPlace • 23 Apr 2024 • 04:15 pm
OPCH Stock Earnings: Option Care Health Beats EPS, Beats Revenue for Q1 2024
GlobeNewswire • 23 Apr 2024 • 11:03 am
Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024
Zacks Investment Research • 22 Apr 2024 • 05:24 pm
Will Option Care (OPCH) Beat Estimates Again in Its Next Earnings Report?
Nasdaq • 22 Apr 2024 • 02:48 pm
First Week of June 21st Options Trading For Option Care Health (OPCH)
Yahoo Finance • 22 Apr 2024 • 02:02 pm
Should You Investigate Option Care Health, Inc. (NASDAQ:OPCH) At US$31.08?
The Motley Fool • 6 months ago
Why Option Care Health Stock Plummeted Today

Option Care Health Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue1.9%1,1461,1241,0931,0691,0161,0271,021981916927892860759141127741705721616497476
Cost Of Revenue--------------------127121
Gross Profit-3.5%23924725425122923121821720121220319916518417416615817613810198.00
Operating Expenses4.2%16916317316816216315715814915115015113613914014314916214910993.00
  S&GA Expenses4.7%15514815815414814814214213413713513412012312312512914413399.0083.00
EBITDA Margin-2.7%0.11*0.11*0.11*0.11*0.08*0.08*0.08*0.08*0.08*0.07*0.09*0.11*---------
Interest Expenses-2.1%12.0012.0012.0013.0014.0015.0014.0013.0012.0014.0016.0017.0019.0024.0025.0031.0028.0030.0022.0012.0011.00
Income Taxes-43.9%12.0022.0014.0041.0015.0017.0013.0014.0011.00-28.523.001.001.001.001.001.001.001.004.00-5.40-1.42
Earnings Before Taxes-27.8%57.0079.0070.0015654.0065.0052.0048.0041.0047.0039.0033.00-1.5818.002.00---38.91--14.01-10.27
EBT Margin-2.2%0.08*0.08*0.08*0.08*0.05*0.05*0.05*0.05*0.04*0.03*0.03*0.03*---------
Net Income-21.7%45.0057.0056.0011439.0048.0039.0034.0030.0075.0035.0032.00-2.8618.002.00-7.67-19.91-15.81-42.79-13.60-3.71
Net Income Margin-0.9%0.06*0.06*0.06*0.06*0.04*0.04*0.05*0.05*0.05*0.04*0.03*0.03*---------
Free Cashflow-340.0%-74.6031.0053.0016284.0025.0080.0010027.0051.0046.0070.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets1.0%3,2503,2173,2443,3213,1303,1133,0732,9862,8782,7912,7862,7192,6402,6472,6682,6262,6132,5902,582601597
  Current Assets3.2%1,1301,0941,1161,1981,030994952877806710811736665657676638601559545178171
    Cash Equivalents-36.2%22034438644129829425520414611920115810999.0014011877.0067.0053.0047.0038.00
  Inventory-11.7%24227425126325022423623221718319017417415915514913911610928.0027.00
  Net PPE0.3%12112110810710610896.0010510911210711111612111311812613313227.0028.00
  Goodwill0%1,5401,5401,5401,5411,5341,5331,5331,5121,4791,47833.001,4291,4291,4291,4291,4291,4281,4261,419632-
Liabilities1.4%1,8201,7951,8041,8461,7801,7271,7361,7011,6571,6151,6891,6621,6221,6321,6751,7581,7421,6831,660676657
  Current Liabilities3.0%637618624668619565587555508460486460420434433395379330320116116
  Long Term Debt0.0%1,0561,0571,0571,0571,0581,0581,0591,0591,0591,0601,1181,1191,1211,1241,1721,2851,2861,2861,266519507
    LT Debt, Current0%6.006.006.006.006.006.006.006.006.006.0012.0012.0012.009.009.009.009.009.007.00--
    LT Debt, Non Current-100.0%-1,0571,0571,0571,0581,0581,0591,0591,0591,0601,1181,1191,1211,1151,1631,2751,2761,2771,259--
Shareholder's Equity0.5%1,4291,4221,4401,4751,3501,3861,3371,2851,2221,1761,0971,0571,0181,016993868870907922584597
  Retained Earnings9.8%50245840034423019014310470.0040.00-35.60-71.08-102-100-117-119-111-91.95-76.14-787-771
  Additional Paid-In Capital0.1%1,2061,2041,1981,1881,1811,1771,1721,1681,1431,1391,1351,1331,1301,1291,1291,0091,0091,0081,008614616
Accumulated Depreciation0.5%124124-----------------76.00104
Shares Outstanding-0.4%174175177180180182182181180180180180---------
Float----5,844---4,018---2,452---473---337-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-235.0%-68,78450,96961,038169,53689,75243,45587,138104,27332,68165,31051,22573,65418,38025,66448,33834,98718,40322,897-5,83613,3269,080
  Share Based Compensation26.9%9,6057,5719,2357,6855,9884,2024,0054,3984,1783,3292,5162,5251,2053321,1706617572722,745569584
Cashflow From Investing63.1%-5,820-15,781-14,316-20,649-5,760-3,626-34,474-64,593-5,359-80,945-4,936-22,537-3,123-14,004-3,602-3,375-5,353-15,142-704,818-3,135-4,731
Cashflow From Financing36.1%-49,732-77,828-101,399-5,497-80,402-1,111-1,24218,766-1,145-65,798-2,959-2,953-5,160-52,442-22,7889,243-2,8626,512716,588-1,038-3,038
  Buy Backs-46.7%40,05075,153100,108-73575,735----------------

OPCH Income Statement

2024-03-31
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
NET REVENUE$ 1,146,052$ 1,015,848
COST OF REVENUE907,552786,843
GROSS PROFIT238,500229,005
OPERATING COSTS AND EXPENSES:  
Selling, general and administrative expenses154,742147,866
Depreciation and amortization expense14,72814,514
Total operating expenses169,470162,380
OPERATING INCOME69,03066,625
OTHER INCOME (EXPENSE):  
Interest expense, net(13,202)(13,834)
Equity in earnings of joint ventures1,1251,437
Other, net21
Total other expense(12,075)(12,396)
INCOME BEFORE INCOME TAXES56,95554,229
INCOME TAX EXPENSE12,16415,021
NET INCOME44,79139,208
OTHER COMPREHENSIVE INCOME (LOSS), NET OF TAX:  
Change in unrealized gain (loss) on cash flow hedges, net of income tax (expense) benefit of $(454) and $1,152, respectively1,551(3,443)
OTHER COMPREHENSIVE INCOME (LOSS)1,551(3,443)
NET COMPREHENSIVE INCOME$ 46,342$ 35,765
EARNINGS PER COMMON SHARE:  
Earnings per share, basic (in dollars per share)$ 0.26$ 0.22
Earnings per share, diluted (in dollars per share)$ 0.26$ 0.21
Weighted average common shares outstanding, basic (in shares)173,928181,262
Weighted average common shares outstanding, diluted (in shares)175,624182,735

OPCH Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
CURRENT ASSETS:  
Cash and cash equivalents$ 219,513$ 343,849
Accounts receivable, net573,650377,658
Inventories241,948274,004
Prepaid expenses and other current assets94,60398,744
Total current assets1,129,7141,094,255
NONCURRENT ASSETS:  
Property and equipment, net120,969120,630
Operating lease right-of-use asset87,78984,159
Intangible assets, net19,31720,092
Referral sources, net307,482315,304
Goodwill1,540,2461,540,246
Other noncurrent assets44,04542,349
Total noncurrent assets2,119,8482,122,780
TOTAL ASSETS3,249,5623,217,035
CURRENT LIABILITIES:  
Accounts payable485,736426,513
Accrued compensation and employee benefits42,62492,508
Accrued expenses and other current liabilities83,38375,010
Current portion of operating lease liability19,20918,278
Current portion of long-term debt6,0006,000
Total current liabilities636,952618,309
NONCURRENT LIABILITIES:  
Long-term debt, net of discount, deferred financing costs and current portion1,056,2821,056,650
Operating lease liability, net of current portion89,20785,484
Deferred income taxes37,88434,920
Other noncurrent liabilities890
Total noncurrent liabilities1,183,4621,177,054
Total liabilities1,820,4141,795,363
STOCKHOLDERS’ EQUITY:  
Preferred stock; $0.0001 par value; 12,500,000 shares authorized, no shares outstanding as of March 31, 2024 and December 31, 202300
Common stock; $0.0000 par value: 250,000,000 shares authorized, 183,397,817 shares issued and 173,816,056 shares outstanding as of March 31, 2024; 182,905,559 shares issued and 174,575,537 shares outstanding as of December 31, 20231818
Treasury stock; 9,581,761 and 8,330,022 shares outstanding, at cost, as of March 31, 2024 and December 31, 2023, respectively(295,396)(255,107)
Paid-in capital1,205,6931,204,270
Retained earnings502,304457,513
Accumulated other comprehensive income16,52914,978
Total stockholders’ equity1,429,1481,421,672
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY$ 3,249,562$ 3,217,035

About Option Care Health Inc

OPCH
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
 CEO
 WEBSITEoptioncarehealth.com
 INDUSTRYHealthcare Plans
 EMPLOYEES5597

Option Care Health Inc Frequently Asked Questions

What is the ticker symbol for Option Care Health Inc? What does OPCH stand for in stocks?

OPCH is the stock ticker symbol of Option Care Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Option Care Health Inc (OPCH)?

As of Thu Apr 25 2024, market cap of Option Care Health Inc is 5.4 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of OPCH stock?

You can check OPCH's fair value in chart for subscribers.

What is the fair value of OPCH stock?

You can check OPCH's fair value in chart for subscribers. The fair value of Option Care Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Option Care Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for OPCH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Option Care Health Inc a good stock to buy?

The fair value guage provides a quick view whether OPCH is over valued or under valued. Whether Option Care Health Inc is cheap or expensive depends on the assumptions which impact Option Care Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for OPCH.

What is Option Care Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Apr 25 2024, OPCH's PE ratio (Price to Earnings) is 19.81 and Price to Sales (PS) ratio is 1.22. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. OPCH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Option Care Health Inc's stock?

In the past 10 years, Option Care Health Inc has provided 0.004 (multiply by 100 for percentage) rate of return.